PROM1 and neoplasm: In addition, highly metastatic CD133- sub-populations of cancer-initiating cells have been identified in a human CRC xenograft model, suggesting that CD133+ tumour cells might give rise to a more aggressive CD133- subset during the metastatic transition [244].